Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Autophagy and Endoplasmic Reticulum Stress in HFpEF
Author(s): Citrawati Dyah Kencono Wungu , Hendri Susilo , Cleodylon Reinard Susanto , et al Added: 6 days ago

Heart Failure

MI/ACS
Ethical and Regulatory Frameworks Post-AI Act in Clinical Research
Author(s): Andrea Barucci , Valentina Colcelli , Salvatore De Masi , et al Added: 1 month ago

Digital Health

Guidelines & Statements
Lynne Brown
Job title: Associate Director, Clinical Marketing
Lynne Brown is an Associate Director of Clinical Marketing at Philips Healthcare, with responsibility for cardiovascular ultrasound products and advanced imaging technologies. Her work focuses on clinical strategy, education, and product adoption in cardiac imaging, drawing on more than 20 years of experience in echocardiography and clinical ultrasound practice.Professional ExperienceBrown joined… View more
We are a global, broad-based healthcare company devoted to discovering new medicines, new technologies and new ways to manage health. Our products span the continuum of care, from nutritional products and laboratory diagnostics, through medical devices and pharmaceutical therapies. Our comprehensive line of products encircles life itself – addressing important health needs from infancy to the… View more
Ethical Challenges in Scientific Publishing: Insights from ESC 2025
Author(s): Alessandro Mugelli Added: 3 months ago

Guidelines & Statements
TTR Therapies Show Delayed Mortality Benefit in ATTR-CM
Added: 5 days ago Source:  Radcliffe Cardiology
Therapies for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), including transthyretin (TTR) stabilisers and silencers, have demonstrated a mortality benefit in randomised trials. However, the timing of this benefit has been a subject of debate. A new analysis of three major outcomes trials has evaluated this time course, revealing a consistent pattern across different treatments… View more

Heart Failure
Occlutech PFO Closure Device: A Long-Term Review
Author(s): Daniela Trabattoni Added: 2 years ago
A single centre, prospective, non-randomised study from DrDaniela Trabattoni (Monzino Cardiology Centre,Milan, IT) following device implantation of the Occlutech PFO Closure device in 442 consecutive patients.The study is particularly interesting due to the scarcity of data available on the long term follow up (over 5 years after) of device implantation. Also, the results are focussed not only… View more

Intervention
Research Area(s) / Expertise:

Expertise

Digital Health
Job title: Senior Medical Assessor
Former Vice President, Research & Development, ReCor Medical Mr Wu has over 20 years of experience in medical device product development. He has worked on devices in the fields of interventional cardiology, electrophysiology, pulmonology, and women’s health, and has taken a number of them from early concept phase through clinical or commercial launch. View more
ESC 25: The SEMA-VR CardioLink-15 Trial
Author(s): Subodh Verma Added: 5 months ago
ESC Congress 2025 - The SEMA-VR CardioLink-15 trial revealed that semaglutide may enhance endogenous progenitor cell-mediated vasculogenic repair processes.Dr Subodh Verma (University of Toronto, Toronto, CA) joins us to discuss the findings from the SEMA-VR CardioLink-15 trial. The study compared usual care with semaglutide, GLP-1RA for six months in 46 patients with either type 2 diabetes… View more

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions